Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Progesterone Receptor
100%
Receptor Expression
100%
Endometrioid Carcinoma
100%
Pathogenesis
100%
Atypical Hyperplasia
66%
Endometrium Carcinoma
50%
Neoplasm
33%
Enhancer Region
33%
Chromatin Immunoprecipitation
33%
Estrogen Receptor
16%
Protein Expression
16%
Epithelial Cell
16%
Immunohistochemistry
16%
Tumor Progression
16%
Progesterone
16%
Keyphrases
ARID1A
100%
Progesterone Receptor Expression
100%
Endometrioid Carcinoma
100%
Pten
28%
Endometrial Carcinoma
21%
Progesterone Receptor
14%
Chromatin Immunoprecipitation (ChIP)
14%
Atypical Hyperplasia
14%
Endometrial Hyperplasia
14%
Human Samples
14%
Enhancer Region
14%
Estrogen Receptor
7%
Risk Factors
7%
Murine Model
7%
Expression Level
7%
Immunohistochemistry
7%
Unresponsiveness
7%
Mutated Genes
7%
Isogenic
7%
Tumor Development
7%
Conditional Knockout
7%
Tumor Progression
7%
Protein Expression Level
7%
Intraepithelial Neoplasia
7%
Progesterone Therapy
7%
BRG1
7%
Endometrial Epithelial Cells
7%
Early-stage Tumor
7%